326 related articles for article (PubMed ID: 21756046)
1. Nanoparticle distribution and temperature elevations in prostatic tumours in mice during magnetic nanoparticle hyperthermia.
Attaluri A; Ma R; Qiu Y; Li W; Zhu L
Int J Hyperthermia; 2011; 27(5):491-502. PubMed ID: 21756046
[TBL] [Abstract][Full Text] [Related]
2. Identification of infusion strategy for achieving repeatable nanoparticle distribution and quantification of thermal dosage using micro-CT Hounsfield unit in magnetic nanoparticle hyperthermia.
LeBrun A; Joglekar T; Bieberich C; Ma R; Zhu L
Int J Hyperthermia; 2016; 32(2):132-43. PubMed ID: 26758242
[TBL] [Abstract][Full Text] [Related]
3. Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo.
Jordan A; Scholz R; Wust P; Fähling H; Krause J; Wlodarczyk W; Sander B; Vogl T; Felix R
Int J Hyperthermia; 1997; 13(6):587-605. PubMed ID: 9421741
[TBL] [Abstract][Full Text] [Related]
4. Real-time infrared thermography detection of magnetic nanoparticle hyperthermia in a murine model under a non-uniform field configuration.
Rodrigues HF; Mello FM; Branquinho LC; Zufelato N; Silveira-Lacerda EP; Bakuzis AF
Int J Hyperthermia; 2013 Dec; 29(8):752-67. PubMed ID: 24138472
[TBL] [Abstract][Full Text] [Related]
5. Magnetic nanoparticle hyperthermia for prostate cancer.
Johannsen M; Thiesen B; Wust P; Jordan A
Int J Hyperthermia; 2010; 26(8):790-5. PubMed ID: 20653418
[TBL] [Abstract][Full Text] [Related]
6. An in-vivo experimental study of temperature elevations in animal tissue during magnetic nanoparticle hyperthermia.
Salloum M; Ma R; Zhu L
Int J Hyperthermia; 2008 Nov; 24(7):589-601. PubMed ID: 18979310
[TBL] [Abstract][Full Text] [Related]
7. Preparation of carboplatin-Fe@C-loaded chitosan nanoparticles and study on hyperthermia combined with pharmacotherapy for liver cancer.
Li FR; Yan WH; Guo YH; Qi H; Zhou HX
Int J Hyperthermia; 2009 Aug; 25(5):383-91. PubMed ID: 19391033
[TBL] [Abstract][Full Text] [Related]
8. Magnetic nanoparticle hyperthermia enhances radiation therapy: A study in mouse models of human prostate cancer.
Attaluri A; Kandala SK; Wabler M; Zhou H; Cornejo C; Armour M; Hedayati M; Zhang Y; DeWeese TL; Herman C; Ivkov R
Int J Hyperthermia; 2015 Jun; 31(4):359-74. PubMed ID: 25811736
[TBL] [Abstract][Full Text] [Related]
9. MicroCT image-generated tumour geometry and SAR distribution for tumour temperature elevation simulations in magnetic nanoparticle hyperthermia.
Lebrun A; Manuchehrabadi N; Attaluri A; Wang F; Ma R; Zhu L
Int J Hyperthermia; 2013 Dec; 29(8):730-8. PubMed ID: 24074039
[TBL] [Abstract][Full Text] [Related]
10. Anticancer effect and feasibility study of hyperthermia treatment of pancreatic cancer using magnetic nanoparticles.
Wang L; Dong J; Ouyang W; Wang X; Tang J
Oncol Rep; 2012 Mar; 27(3):719-26. PubMed ID: 22134718
[TBL] [Abstract][Full Text] [Related]
11. Heat shock protein expression and temperature distribution in prostate tumours treated with laser irradiation and nanoshells.
Rylander MN; Stafford RJ; Hazle J; Whitney J; Diller KR
Int J Hyperthermia; 2011; 27(8):791-801. PubMed ID: 22098363
[TBL] [Abstract][Full Text] [Related]
12. Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model.
Johannsen M; Thiesen B; Jordan A; Taymoorian K; Gneveckow U; Waldöfner N; Scholz R; Koch M; Lein M; Jung K; Loening SA
Prostate; 2005 Aug; 64(3):283-92. PubMed ID: 15726645
[TBL] [Abstract][Full Text] [Related]
13. Repeated inductive heating using a sintered MgFe2O4 needle for minimally invasive local control in breast cancer therapy.
Yukumi S; Watanabe Y; Horiuchi A; Doi T; Sato K; Yoshida M; Yamamoto Y; Maehara T; Aono H; Naohara T; Kawachi K
Int J Hyperthermia; 2009; 25(6):416-21. PubMed ID: 19533484
[TBL] [Abstract][Full Text] [Related]
14. On the optimal choice of the exposure conditions and the nanoparticle features in magnetic nanoparticle hyperthermia.
Bellizzi G; Bucci OM
Int J Hyperthermia; 2010; 26(4):389-403. PubMed ID: 20210609
[TBL] [Abstract][Full Text] [Related]
15. Cancer hyperthermia using magnetic nanoparticles.
Kobayashi T
Biotechnol J; 2011 Nov; 6(11):1342-7. PubMed ID: 22069094
[TBL] [Abstract][Full Text] [Related]
16. Prospective treatment planning to improve locoregional hyperthermia for oesophageal cancer.
Kok HP; van Haaren PM; van de Kamer JB; Zum Vörde Sive Vörding PJ; Wiersma J; Hulshof MC; Geijsen ED; van Lanschot JJ; Crezee J
Int J Hyperthermia; 2006 Aug; 22(5):375-89. PubMed ID: 16891240
[TBL] [Abstract][Full Text] [Related]
17. Controlling nanoparticle delivery in magnetic nanoparticle hyperthermia for cancer treatment: experimental study in agarose gel.
Salloum M; Ma RH; Weeks D; Zhu L
Int J Hyperthermia; 2008 Jun; 24(4):337-45. PubMed ID: 18465418
[TBL] [Abstract][Full Text] [Related]
18. MicroPET-compatible, small animal hyperthermia ultrasound system (SAHUS) for sustainable, collimated and controlled hyperthermia of subcutaneously implanted tumours.
Singh AK; Moros EG; Novak P; Straube W; Zeug A; Locke JE; Myerson RJ
Int J Hyperthermia; 2004 Feb; 20(1):32-44. PubMed ID: 14612312
[TBL] [Abstract][Full Text] [Related]
19. Experience with a small animal hyperthermia ultrasound system (SAHUS): report on 83 tumours.
Novák P; Moros EG; Parry JJ; Rogers BE; Myerson RJ; Zeug A; Locke JE; Rossin R; Straube WL; Singh AK
Phys Med Biol; 2005 Nov; 50(21):5127-39. PubMed ID: 16237245
[TBL] [Abstract][Full Text] [Related]
20. Enhancement in treatment planning for magnetic nanoparticle hyperthermia: optimization of the heat absorption pattern.
Salloum M; Ma R; Zhu L
Int J Hyperthermia; 2009 Jun; 25(4):309-21. PubMed ID: 19670098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
